mastering the art of precision in the treatment of hr early and metastatic breast cancer
Published 9 months ago • 1.1K plays • Length 1:25:24Download video MP4
Download video MP3
Similar videos
-
59:12
making precision decisions in high-risk hr , her2- metastatic breast cancer
-
1:09:24
raising the bar in hr /her2- early breast cancer: cdk4 and 6 inhibitors
-
57:18
navigating the expanding treatment arsenal for er /her2- breast cancer
-
1:16:56
navigating the integration of trop2-targeted therapy in tnbc and hr , her2- breast cancer
-
51:40
trop2-targeting adcs as new tools in the tnbc and hr /her2- breast cancer treatment arsenal
-
54:02
navigating shifts in the treatment landscape for metastatic her2-positive breast cancer
-
1:03:59
selecting and sequencing of her2-targeting therapies in her2-positive metastatic breast cancer
-
1:01:02
surprising breast cancer facts that will change your life forever!
-
55:30
breaking down barriers to treatment adherence and persistence in hr /her2- early breast cancer
-
29:21
new advances and opportunities for improvement in hr /her2- early breast cancer
-
7:40
cdk4/6 inhibitors in the first-line treatment setting
-
32:54
raising the bar in her2-positive breast cancer
-
4:22
how to use endocrine therapy in premenopausal women with er metastatic breast cancer
-
1:02:48
expanding treatment options in er /her2- breast cancer: serds, serms, sercas, and more
-
1:33:57
evaluating the evidence and parsing the practicalities of therapeutic choices in hr breast cancer
-
58:22
adjuvant cdk4 and 6 inhibition to prevent recurrences in high-risk hr /her2- early breast cancer
-
1:25:12
a guide for selection, sequencing, and optimal use of her2-targeted therapies in her2 breast cancer
-
23:51
2022 west oncology conference | precision oncology in hr breast cancer
-
0:29
5 symptoms of breast cancer | warning signs of breast cancer | dr niharika garach